Cambridge, Massachusetts, December 15, 2022 /PRNewswire/ — Flagship Pioneering, a bioplatform innovator, and Invaio Sciences, a company bringing the technology behind precision medicine to plant health, today announced: Jonathan Schwartz He will join Flagship Pioneering as CEO Partner and become Invaio’s Chief Executive Officer and a member of the Board of Directors.
Schwartz has an impressive track record in building technology-enabled businesses. His career has spanned both technology his systems and healthcare, leading companies through scaling, mergers, acquisitions and fundraising.
Prior to joining Invaio, Schwartz was President and CEO of CareZone, Inc., a company focused on helping individuals and families manage their medications. CareZone was acquired by Walmart, Inc. Prior to Sun Microsystems, Inc.’s acquisition by Oracle Corp., he was the CEO and Director of Sun Microsystems, Inc., a software company. He is the founder, president, and CEO of Lighthouse Design, Ltd. was. In 1996 he was acquired by Sun Microsystems. Schwartz started his career at his McKinsey & Co.
Dr. Nubar Afeyan, Founder and CEO of Flagship Pioneering and co-founder of InVio, said: Jonathan’s proven success in creating value and driving innovation will bring significant benefits to our company and help take InVio to the next level. ”
“InVio is on an impressive trajectory of growth and Jonathan will help InVio reach its ambitious goal of making every acre better for today and for generations to come. He’s the best leader to do.” Ignacio MartinezFlagship Pioneer General Partner, Co-Founder and Director of Invaio.
“Nothing is more important to us and our planet than the health of our food system. Jonathan Schwartz, CEO and Director of Invaio. “By leveraging the same bio-platform that has transformed human healthcare, Invaio’s innovations will provide producers, workers, and ultimately consumers with far greater insight and a safer, healthier alternative.” and enable sustainable agricultural practices.”
Invaio is a naturally positive agricultural company. The company solves performance and delivery challenges in crop health, enabling farmers to use more natural and effective crop health solutions that care for the entire crop system. Founded by Flagship Pioneering in 2018, Invaio is responsive to consumer demands, delivering fundamental benefits to farmers and the environment, making every acre better for current and future generations. . For more information, please visit www.invaio.com or follow Invaio. twitter or LinkedIn.
About flagship development
Flagship Pioneering conceives, creates, resources and develops the industry’s first bio-platform companies to transform human health and sustainability. Since its founding in 2000, the company has applied a unique hypothesis-driven innovation process through its flagship lab units to create and nurture over 100 scientific ventures. $100 billion with an aggregate value.To date, Flagship has $3.1 billion Providing capital for the establishment and growth of pioneer companies, $19 billion of additional investment from other institutions. The current flagship ecosystem is Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Indigo AgModerna (NASDAQ: mRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB).
Source InVio Sciences